De La Garza_2008_Pharmacol.Biochem.Behav_89_200

Reference

Title : The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers - De La Garza_2008_Pharmacol.Biochem.Behav_89_200
Author(s) : De La Garza R, 2nd , Mahoney JJ, 3rd , Culbertson C , Shoptaw S , Newton TF
Ref : Pharmacol Biochem Behav , 89 :200 , 2008
Abstract : De La Garza_2008_Pharmacol.Biochem.Behav_89_200
ESTHER : De La Garza_2008_Pharmacol.Biochem.Behav_89_200
PubMedSearch : De La Garza_2008_Pharmacol.Biochem.Behav_89_200
PubMedID: 18207225

Related information

Citations formats

De La Garza R, 2nd, Mahoney JJ, 3rd, Culbertson C, Shoptaw S, Newton TF (2008)
The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers
Pharmacol Biochem Behav 89 :200

De La Garza R, 2nd, Mahoney JJ, 3rd, Culbertson C, Shoptaw S, Newton TF (2008)
Pharmacol Biochem Behav 89 :200